Vax-Immune

Vax-Immune is a Houston-based biotechnology company focused on developing innovative point-of-care diagnostic tools and vaccines to combat infectious diseases, with a primary emphasis on maternal and infant health. The company's flagship technology, the 'Lab-in-a-Comb,' is a rapid, cost-effective diagnostic platform designed to detect pathogens like Group B Streptococcus (GBS) and those causing urinary tract infections in clinical settings. By providing real-time results, Vax-Immune aims to reduce the reliance on prophylactic antibiotics and improve clinical outcomes for pregnant women and their newborns. Additionally, the company is working on vaccine candidates to provide long-term protection against these prevalent bacterial infections. Vax-Immune leverages its proprietary technology to bridge the gap between laboratory testing and immediate clinical decision-making.